Podcasts about Health economics

Send us a textThe obsession with calculating the "cost of ob*sity" to society reflects our troubling tendency to commodify human life and health. In this rather ragey and explosive episode, I expose how a widely-cited figure of £98 billion was manufactured by pharmaceutical interests to sell weight loss drugs. I challenge the notion that we "owe" society a debt of health and explore how weight stigma, not weight itself, drives depression and poor health outcomes. Through a rather provocative thought experiment, I reveal the absurdity of reducing human experience to economic calculations and argue that tackling stigma, not eradicating fatness, is the real path forward. Today's journal article was:  Stevens, Serena D et al. “Adult and childhood weight influence body image and depression through weight stigmatization.” Journal of health psychology vol. 22,8 (2017): 1084-1093. doi:10.1177/1359105315624749 Got a question for the next podcast? Let me know! Connect With Me FREE GUIDES: evidence-based, not diet nonsense NEWSLETTER: Life-changing insights straight to your inbox UNSHRINKABLE: Find out why your body is not designed to shrink MASTERCLASSES: All the evidence doctors should give you NO WEIGH PROGRAM: Join the revolution against weight-loss lies THE WEIGHTING ROOM: A community where authenticity thrives and every voice matters CONSULTATION: For the ultimate transformation in your healthcare journe Find me on Instagram, YouTube, and LinkedIn.

(02:00): Zelenskyj vil have Trump med til fredsforhandlinger - fordele og ulemper? Medvirkende: Stefan Weichert, journalist i Ukraine. (11:00): Trump langer ud efter Novo Nordisk og lover lavere medicinpriser. Medvirkende: Lars Holger Ehlers, tidligere professor i sundhedsøkonomi, i dag direktør i Nordic Institute of Health Economics. (30:00): Børns Vilkår: Det er vigtigt, at præster underretter, når de hører om svigtede børn. Medvirkende: Anne Kappelgaard Bové, seniorkonsulent, Børns Vilkår. Værter: Anne Philipsen & Nicolai DandanellSee omnystudio.com/listener for privacy information.

(00:00): Ekspert analyserer Ukraine og Ruslands tilsyneladende tilnærmelser. Medvirkende: Flemming Splidsboel Hansen, seniorforsker hos DIIS med speciale i Rusland og det postsovjetiske område. (13:00): PKK opløses og den væbnede kamp mod Tyrkiet indstilles. Medvirkende: Deniz Serinci, forfatter med speciale i de tyrkiske forhold. (30:00): USA og Kina sætter dele af toldkrigen på pause i 90 dage. Medvirkende: Rune Møller Stahl, Senioranalytiker ved Oxfam Danmark, der tidligere har forsket i international politisk økonomi ved CBS. (37:00): Trump vil sænke prisen på lægemidler med 30-80 procent i USA. Medvirkende: Lars Holger Ehlers, tidligere professor i sundhedsøkonomi, i dag direktør i Nordic Institute of Health Economics. Værter: Anne Phillipsen og Nicolai Dandanell See omnystudio.com/listener for privacy information.

ISPOR 2025, the leading global conference for Health Economics and Outcomes Research (HEOR), takes place 13th-16th May and marks the 30th anniversary of the organisation. Ahead of the event, web editor Nicole Raleigh spoke with Rob Abbott, CEO and executive director of ISPOR – the leading professional society for HEOR globally – about the ins and outs and trends of HEOR. ISPOR's mission is to advance HEOR excellence to improve decision making for health globally, and Abbott explains its focus on the value of particular healthcare interventions, the impact on the quality of life of patients, and how his work is centred around positioning HEOR as a key lever for decision makers and shapers globally to create a world in which healthcare is accessible, effective, efficient, and affordable for everyone. You can listen to episode 177a of the pharmaphorum podcast in the player below, download the episode to your computer, or find it - and subscribe to the rest of the series - in iTunes, Spotify, Amazon Music, Podbean, and pretty much wherever you get your other podcasts!

In this episode of Pharmacy Podcast that provides regular interviews with Pharmacy leaders, entrepreneurs, and members of The Independent Pharmacies of Australia (IPA), host Melody Mugari, a Pharmacist and Programs and Corporate Partnerships Manager at Independent Pharmacies Australia (IPA) sits down with Nader Mitri, General Manager of PharmaPrograms, to explore how innovation, strategic thinking, and patient-first models are reshaping the Pharmacy landscape. With over two decades of experience, including owning three community pharmacies and holding a Master's in Health Economics, Nader brings deep industry insight into how Pharmacists can expand their impact beyond the dispensary. Together, Melody and Nader unpack the challenges, opportunities, and future pathways for Pharmacists looking to create meaningful, lasting change in healthcare delivery.

Send us a textDr. Mirza Rahman, MD, MPH serves as the President of the American College of Preventive Medicine ( ACPM - https://www.acpm.org/about-acpm/governance/executive-officers/mirza-rahman/ ), a professional community, founded in 1954 as a professional community for board-certified physicians to network, share their expertise and advocate for the advancement of prevention. Today, ACPM represents over 2,000 physicians, medical students, non-physicians, and other partners. All believe in the importance of preventive medicine in our society. Dr. Rahman also serves as the Senior Vice President, Patient Safety & Pharmacovigilance at Cybin ( https://cybin.com/our-team/ ), a pharmaceutical company seeking to bring novel, second-generation psychedelics to market. He also and is a Co-Founder and President of the Guyanese Diaspora Charity ( https://www.guyanesediasporacharity.org/ ), a 501(c)(3) non-profit organization focused on helping to improve the lives of Guyanese. In addition, Dr. Rahman is an Adjunct Associate Professor of Epidemiology at Columbia University ( https://www.publichealth.columbia.edu/profile/mirza-i-rahman-md ) and as an Adjunct Associate Professor at the University of Guyana.Most recently, Dr. Rahman was the Vice President & Chief Safety Officer at Organon, a global healthcare company. There, he was responsible for leading and setting the broad strategic direction for pharmacovigilance for this multinational company.Prior to that, Dr. Rahman was the Senior Vice President, Chief Global Pharmacovigilance Officer & European Research & Development Lead at Otsuka Pharmaceuticals, a global Japanese based pharmaceutical company. In 2013, he created the ACPM - Otsuka Pharmacovigilance Physician Program in Global Medical Safety. Dr. Rahman joined Otsuka from Merck Research Laboratories, where he was an Executive Director in the Clinical Risk Management/Global Safety department. Before this, he worked at Johnson & Johnson in a variety of positions, serving as a Worldwide Vice President, Health Economics & Reimbursement at Ortho-Clinical Diagnostics in his last role there.During his 25+ years in the pharmaceutical industry, while Dr. Rahman has worked primarily in Pharmacovigilance, he has also worked in Medical Affairs, Medical Information, Health Economics and Outcomes Research, Quality Management, Clinical Development, Manufacturing, and Regulatory Affairs.Dr. Rahman completed his Public Health & General Preventive Medicine Residency along with his Family Medicine Residency at Stony Brook University. He completed the Advanced Management Program at the Columbia Business School and earned his Master of Public Health degree from the Columbia University School of Public Health. Dr. Rahman earned his Doctor of Medicine degree from the Stony Brook University School of Medicine, and his Bachelor of Science degree from the Sophie Davis School of Biomedical Education at the City College of the City University of New York. #MirzaRahman #AmericanCollegeOfPreventiveMedicine #PatientSafety #Pharmacovigilance #GuyaneseDiasporaCharity #Epidemiology #ColumbiaUniversity #UniversityOfGuyana #MedicalAffairs #HealthEconomics #OutcomesResearch #QualityManagement #ClinicalDevelopment #RegulatoryAffairs #PublicHealth #BrainHealth #DiabetesPrevention #ReducingHypertension #LifestyleMedicine #PopulationHealth #ViolencePrevention #Psychedelics #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcast #STEM #Innovation #Science #Technology #ResearchSupport the show

Send us a textDiscover how health economics can support successful Medical Device launch, proposition development, and market accessThis episode offers an insightful journey into the world of medical device market access. Specialists from our health economics and market access teams explore the hidden challenges faced by medical devices companies when taking new innovations to healthcare leaders, communicating value and demonstrating evidence, and offer tips on leveraging health economics for a successful launch.Juliet Wallace (Senior Partnerships Coordinator) delves deep with our expert panel into the pivotal role of health economic evaluation in supporting market access for medical devices. Juliet puts audience questions to Hannah Palin (Director, Local Market Access), Calum Jones (Associate Director, Health Economics), and Evelyne Priestman (Consultant, Health Economics).See full details at: https://mtechaccess.co.uk/launch-strategies-health-economic-modelling-medical-devices/This episode was originally broadcast live as webinar in February 2025. https://petauri.com/Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

Send us a textDr. Blythe Adamson, PhD, MPH ( https://www.blytheadamson.com/ ) is Head of Outcomes Research and Evidence Generation at Flatiron Health ( https://flatiron.com/ ), where her work has been focused on developing deep learning language models for extraction of clinical details from EHR documents, ultimately learning from the experience of millions of patients with cancer, and generating evidence of treatment effectiveness and value used by governments around the world. Dr. Adamson is a scientist, epidemiologist and economist ( https://scholar.google.com/citations?user=jAflVcUAAAAJ&hl=en ), who co-invented a patented clinical decision-support tool, enabled by machine learning, that is used by cancer clinics to benefit patients.Formerly a lead data scientist in the West Wing of The White House, Dr. Adamson has been involved in advising public and private institutions including professional sports leagues, the entertainment industry, retailers, manufacturers, and more.Dr. Adamson founded the company Infectious Economics ( https://www.infectiouseconomics.com/ ), with a focus to provide thought leadership to policy makers and industry leaders on cost-effective strategies to prevent the transmission of viruses.Dr. Adamson holds degrees in microbiology, epidemiology, and pharmaceutical economics with a focus on infectious disease prevention, doing her Master of Public Health in Epidemiology, and Ph.D. in Pharmaceutical Outcomes Research and Policy, at the University of Washington, where she still lectures as an Affiliate Assistant Professor ( https://sop.washington.edu/people/blythe-adamson/ ).Dr. Adamson has also held roles at the Bill and Melinda Gates Foundation Institute for Disease Modeling and the NIAID HIV Vaccine Trials Network and is a Board Member of NBA-funded SalivaDirect lab at Yale.#BlytheAdamson #FlatironHealth #EHR #Oncology #Cancer #HIV #InfectiousEconomics #RWE #RealWorldEvidence #ElectronicHealthRecords #RealWorldData #ClinicalDecisions #HealthPolicies #LargeLanguageModels #LLM #AI #ArtificialIntelligence #MachineLearning #ML #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

Are tax hikes really driving up illicit trade, or is the industry narrative just smoke and mirrors? Professor Corné van Walbeek, Director of UCT’s Research Unit on the Economics of Excisable Products (REEP), joins John Maytham to unpack key insights into why beer consumption is thriving despite tax increases, how Treasury’s tiered alcohol tax model is encouraging healthier choices, and why South Africa is losing billions each year to illicit cigarettes. It is a data-driven deep dive into the numbers, the narrative, and the policy path forward.See omnystudio.com/listener for privacy information.

About this episode: As a follow up to our recent episode titled The Potential Impacts of Cuts To Medicaid, we're partnering with our friends at the Tradeoffs podcast. Guest hosts Dan Gorenstein and Ryan Levi, longtime health reporters, take a deeper look at why many Republicans believe a smaller Medicaid program would be a better Medicaid, what proposed cuts might look like, and the challenges Republicans may face in trying to get cuts passed in Congress. Guests: Dan Gorenstein is the executive producer and host of the Tradeoffs Podcast and an adjunct senior fellow at the Leonard Davis Institute of Health Economics at the University of Pennsylvania.   Ryan Levi is a reporter and producer for the Tradeoffs Podcast. Show links and related content: Why Many Republicans Think Shrinking Medicaid Will Make It Better—Tradeoffs The Potential Impacts of Cuts To Medicaid—Public Health On Call (March 2025) The Oregon Experiment—Effects of Medicaid on Clinical Outcomes—The New England Journal of Medicine (2013) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

The Gauteng Department of Health in partnership with the Medical Bureau for Occupational Diseases are rolling out an initiative to trace former mine workers who may be eligible for social security benefits for work-related illnesses and possible provident/pension funds due to them. While the programme will be rolled out across the province, Phase one has already began in the West Rand District due to a large concentration of mines in that area. The Medical Bureau for Occupational Diseases database shows that there are over 2,000 former mine workers in the West Rand with unclaimed benefits, while 7500 more across Gauteng are yet to receive what is rightfully theirs. Sakina Kamwendo spoke to Chief Director of Health Economics & Finance at the Gauteng Department of Health, Siyabonga Jikwana

Today, we are joined by Dr. Kathy Pearson and Dr. Gregg Pearson.Dr. Kathy Pearson, strategist, systems thinking expert, and decision-making authority, is President and Founder of Enterprise Learning Solutions. She is also an Adjunct Senior Fellow at the Leonard Davis Institute of Health Economics and has served as an adjunct Associate Professor in the Operations and Information Management Department at The Wharton School, both at the University of Pennsylvania. Kathy, an award-winning educator, collaborates with Executive Education groups and global organizations across industries like healthcare, finance, and technology, including clients such as Bank of America and Coca-Cola. She holds a BS in theoretical mathematics (Auburn University), an MS in Decision Sciences (Georgia State University), and a PhD in Industrial Engineering (Northwestern University).Dr. Gregg Pearson is a Partner at ELS and an Adjunct Professor of History at Lehigh University and La Salle University. He specializes in nineteenth-century American political history, twentieth-century American cultural history, military history, the history of technology, and business leadership. Gregg spent 16 years in the packaging industry, including as Northeast Region General Manager at Ball Corporation, overseeing $350M in revenue. He holds a PhD in History from Lehigh University, an MA from La Salle University, an MS in Industrial Engineering from Northwestern University, and is a graduate of the United States Military Academy at West Point.In this episode, we explore how Kennedy evolved as a leader, learning from earlier failures to develop a more effective crisis management approach that became the gold standard for leadership under extreme pressure.Key topics include:• How Kennedy's approach evolved from the Bay of Pigs failure to the Cuban Missile Crisis• The critical importance of gathering reliable information before making decisions• Why seeking contrary viewpoints helps leaders avoid confirmation bias• How clear "commander's intent" empowers teams to adapt in changing circumstances• The value of structured post-mortems to learn from both successes and failures-Website and live online programs: http://ims-online.comBlog: https://blog.ims-online.com/Podcast: https://ims-online.com/podcasts/LinkedIn: https://www.linkedin.com/in/charlesgood/Twitter: https://twitter.com/charlesgood99Chapters:(00:00) Introduction(02:00) Setting the Historical Context(04:40) Technique: Avoiding Confirmation Bias in Leadership(07:00) Tip: Making Decisions with Incomplete Information(09:00) Kennedy's Evolution as a Leader(12:00) Tool: The Role of Objective Information in Crisis(16:00) Tip: The Power of Clear Purpose in Uncertain Times(20:40) Tip: Learning from Failure to Improve Decision-Making(25:00) Technique: The Art of Compromise in Leadership(28:00) Tool: Military After-Action Reviews in Business Context(31:00) Conclusion

The Minds in Motion Podcast from Dementia Researcher in association with the NIHR Applied Research Collaborations and Alzheimer's Society, brings together NIHR Dem Comm Research Fellows, to talk about their research and careers. In this second series, we hear from five of the Dem Comm Fellows each taking a turn as co-host and guest. Alongside the researchers we have the incredible Trevor Salomon, Alzheimer's Society Volunteer & Chair of the European Dementia Carers Working Group as our permanent co-host and anchor. In show Trevor is joined by the guest from our previous show Dr Lis Grey from University of Bristol and the NIHR Applied Research Collaboration (ARC) West to interview Dr Katie Breheny. Katy works in the NIHR ARC West and University of Bristol. Katie is a health economist focused on improving the way we assess and value healthcare interventions for people living with dementia. Her research explores how traditional health economic methods can be adapted to better capture wellbeing and quality of life in dementia care. With a background in psychology, Katie's work spans health economics, patient-reported outcomes, and methodological research, ensuring that economic evaluations reflect the real-world needs of individuals, carers, and service providers. She is particularly interested in making assessments more inclusive and meaningful, while also working on innovative projects such as adapting wellbeing questionnaires and developing personalised digital tools to support dementia care. Dem Comm is a 2 year programme funded by the National Institute of Health and Care Research and the Alzheimer's Society. It supports a new generation of dementia research leaders, bringing together researchers from different multidisciplinary backgrounds to encourage cross-cutting and community-orientated dementia research projects that can address key gaps in the evidence around dementia care and support, delivering transformative translational research. For information on the Fellowship visit: http://www.arc-wx.nihr.ac.uk/dem-comm-research-fellows For guest biographies, a full transcript and much more visit: http://www.dementiaresearcher.nihr.ac.uk Like what you hear? Please review, like, and share our podcast, and don't forget to subscribe to ensure you never miss an episode. If you prefer to watch rather than listen, you'll find a video version of this podcast on our website, YouTube and Spotify. This podcast is brought to you in association with Alzheimer's Association, Alzheimer's Research UK, Alzheimer's Society and Race Against Dementia, who we thank for their ongoing support. Follow us on Social Media: http://www.instagram.com/dementia_researcher/ http://www.facebook.com/Dementia.Researcher/ http://www.bsky.app/profile/dementiare…archer.bsky.social http://www.linkedin.com/company/dementia-researcher

This episode has three chapters. Each one answers a key question, and, bottom line, it all adds up to action steps directly and indirectly for many, including plan sponsors probably, community leaders, and also hospital boards of directors. Here's the three chapters in sum. For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. Chapter 1: Are commercial insurance premiums rising faster than the inflation rate? And if so, is the employee portion of those premiums also rising, meaning a double whammy for employees' paychecks (ie, premium costs are getting bigger and bigger in an absolute sense, and also employees' relative share of those bigger costs is also bigger)? Spoiler alert: yes and yes. Chapter 2: What is the biggest reason for these premium increases? Like, if you look at the drivers of cost that underpin those rising premiums, what costs a lot that is making these premiums cost a lot? Spoiler alert: It's hospitals and the price increases at hospitals. And just in case anyone is wondering, this isn't, “Oh, chargemasters went up” or some kind of other tangential factor. We're talking about the revenue that hospitals are taking on services delivered has gone up and gone up way higher than the inflation rate. In fact, hospital costs have gone up over double the amount that premiums have gone up. Wait, what? That's a fact that Dr. Vivian Ho said today that threw my brain for a loop: Hospital costs have gone up over double the amount that premiums have gone up. Chapter 3: Is the reason that hospital prices have rocketed up as they have because the underlying costs these hospitals face are also going up way higher than the inflation rate? Like, for example, are nurses' salaries skyrocketing and doctors are getting paid a lot more than the inflation rate? Stuff like this. Too many eggs in the cafeteria. Way more charity care. Bottom line, is an increase in underlying costs the reason for rising hospital prices? Spoiler alert: no. No to all of the above. And I get into this deeply with Dr. Vivian Ho today. But before I do, I do just want to state with three underlines not all hospitals are the same. But yeah, you have many major consolidated hospitals crying about their, you know, “razor-thin margins” who are, it turns out, incentivizing their C-suites to do things that ultimately wind up raising prices. I saw a PowerPoint flying around—you may have seen it, too—that was apparently presented by a nonprofit hospital at JP Morgan, and it showed this nonprofit hospital with a 15.1% EBITDA (earnings before interest, taxes, depreciation, and amortization) in 2024. Not razor thin in my book. It's a, the boards of directors are structuring C-suite incentives in ways that ultimately will raise prices. If you want to dig in a little deeper on hospital boards and what they may be up to, listen to the show with Suhas Gondi, MD, MBA (EP404). Vivian Ho, PhD, my guest today, is a professor and faculty member at Rice University and Baylor College of Medicine. Her most major role these days is working on health policy at Baker Institute at Rice University. Her work there is at the national, state, and local levels conducting objective research that informs policymakers on how to improve healthcare. Today on the show, Professor Vivian Ho mentions research with Salpy Kanimian and Derek Jenkins, PhD. Alright, so just one quick sidebar before we get into the show. There is a lot going on with hospitals right now. So, before we kick in, let me just make one really important point. A hospital's contribution to medical research, like doing cancer clinical trials, is not the same as how a hospital serves or overcharges their community or makes decisions that increase or reduce their ability to improve the health and well-being of patients and members who wind up in or about the hospital. Huge, consolidated hospital networks can be doing great things that have great value and also, at the exact same time, kind of harmful things clinically and financially that negatively impact lots of Americans and doing all of that simultaneously. This is inarguable. Also mentioned in this episode are Rice University's Baker Institute for Public Policy; Baker Institute Center for Health Policy; Suhas Gondi, MD, MBA; Salpy Kanimian; Derek Jenkins, PhD; Byron Hugley; Michael Strain; Dave Chase; Zack Cooper, PhD; Houston Business Coalition on Health (HBCH); Marilyn Bartlett, CPA, CGMA, CMA, CFM; Cora Opsahl; Claire Brockbank; Shawn Gremminger; Autumn Yongchu; Erik Davis; Ge Bai, PhD, CPA; Community Health Choice; Mark Cuban; and Ferrin Williams, PharmD, MBA. For further reading, check out this LinkedIn post.   You can learn more at Rice University's Center for Health Policy (LinkedIn) and Department of Economics and by following Vivian on LinkedIn.   Vivian Ho, PhD, is the James A. Baker III Institute Chair in Health Economics, a professor in the Department of Economics at Rice University, a professor in the Department of Medicine at Baylor College of Medicine, and a nonresident senior scholar in the USC Schaeffer Center for Health Policy and Economics. Ho's research examines the effects of economic incentives and regulations on the quality and costs of health care. Her research is widely published in economics, medical, and health services research journals. Ho's research has been funded by the National Institutes of Health (NIH), the Agency for Healthcare Research and Quality, the American Cancer Society, and Arnold Ventures. Ho has served on the Board of Scientific Counselors for the National Center for Health Statistics, as well as on the NIH Health Services, Outcomes, and Delivery study section. She was elected as a member of the National Academy of Medicine in 2020. Ho is also a founding board member of the American Society for Health Economists and a member of the Community Advisory Board at Blue Cross Blue Shield of Texas. Ho received her AB in economics from Harvard University, a graduate diploma in economics from The Australian National University, and a PhD in economics from Stanford University.   05:12 Are insurance premiums going up? 05:59 What is the disparity between cost of insurance and wage increases? 06:21 LinkedIn post by Byron Hugley. 06:25 Article by Michael Strain. 06:46 How much have insurance premiums gone up for employers versus employees? 09:06 Chart showing the cost to insure populations of employees and families. 10:17 What is causing hospital prices and insurance premiums to go up so exponentially? 12:53 Article by (and tribute to) Uwe Reinhardt. 13:49 EP450 with Marilyn Bartlett, CPA, CGMA, CMA, CFM. 14:01 EP452 with Cora Opsahl. 14:03 EP453 with Claire Brockbank. 14:37 EP371 with Erik Davis and Autumn Yongchu. 15:28 Are razor-thin operating margins for hospitals causing these rising hospital prices? 16:56 Collaboration with Marilyn Bartlett and the NASHP Hospital Cost Tool. 19:47 What is the explanation that hospitals give for justifying these profits? 23:16 How do these hospital cost increases actually happen? 27:06 Study by Zack Cooper, PhD. 27:35 EP404 with Suhas Gondi, MD, MBA. 27:50 Who typically makes up a hospital board, and why do these motivations incentivize hospital price increases? 30:12 EP418 with Mark Cuban and Ferrin Williams, PharmD, MBA. 33:17 Why is it vital that change start at the board level?   You can learn more at Rice University's Center for Health Policy (LinkedIn) and Department of Economics and by following Vivian on LinkedIn.   Vivian Ho discusses #healthinsurance #premiums and #hospitalpricing on our #healthcarepodcast. #healthcare #podcast #changemanagement #healthcareleadership #healthcaretransformation #healthcareinnovation   Recent past interviews: Click a guest's name for their latest RHV episode! Chris Crawford (EP465), Al Lewis, Betsy Seals, Wendell Potter (Encore! EP384), Dr Scott Conard, Stacey Richter (INBW42), Chris Crawford (EP461), Dr Rushika Fernandopulle, Bill Sarraille, Stacey Richter (INBW41)  

How do we ensure that healthcare is accessible, effective, efficient, and affordable for all? How can a professional society shape global health policy while advancing scientific research?In this episode of Associations Thrive, host Joanna Pineda interviews Rob Abbott, CEO of ISPOR. Rob discusses:ISPOR's role as the professional society for Health Economics and Outcomes Research (HEOR), with a global reach spanning over 100 countries and 20,000 members.How ISPOR is a multi-stakeholder society that includes clinicians, researchers, policymakers, industry professionals, and investors, creating a broad and impactful membership base.The importance of health economics and outcomes research in informing healthcare policy and improving patient outcomes worldwide.ISPOR's recent rebranding from the International Society for Pharmacoeconomics and Outcomes Research to ISPOR – The Professional Society for Health Economics and Outcomes Research, making the organization more inclusive of healthcare professionals.The launch of ISPOR's 2030 strategic plan, which features a bold vision for a world where healthcare is accessible, effective, efficient, and affordable for all.How ISPOR is shifting from primarily curating scientific research to actively engaging in health policy discussions and advocating for evidence-based decision-making.The upcoming launch of ISPOR's Institute for Global Health in 2025, which will focus on emerging healthcare challenges and horizon scanning for high-impact policy interventions.How ISPOR is strengthening its global chapters and partnerships to ensure local expertise informs global policy.The evolution of ISPOR's conferences, including record-breaking attendance and new events in Asia and Latin America to expand engagement in underserved regions.How ISPOR is working to redefine the concept of ‘value' in healthcare, incorporating social determinants of health and a more holistic approach to decision-making.References:ISPOR WebsiteMusic from #Uppbeat (free for Creators!):https://uppbeat.io/t/paul-yudin/quiet-flightLicense code: KJRRI6GHC7WKCLDT

In this episode of The MedTech Talent Lab, host Mitch Robbins sits down with April Spillane, VP of Market Access & Reimbursement at Intrinsic Therapeutics. With over 15 years in the industry—10 of those dedicated to spine—April shares her unique career trajectory, from clinical and business development to leading market access strategies at a high level.She opens up about the challenges of balancing a demanding career with motherhood, the leadership lessons she's learned along the way, and what it truly takes to thrive in market access and reimbursement. April also discusses the evolving healthcare landscape, the complexities of payer policies, and why persistence is key in the fight for patient access to cutting-edge technologies.Whether you're a MedTech leader, aspiring executive, or just curious about the behind-the-scenes battles to bring life-changing medical innovations to market, this episode is packed with valuable insights.Listen now to hear how April is shaping the future of MedTech access and advocacy!

If it benefits the health of the whole country, would you be willing to pay for someone else in Australia to lose weight? Ozempic, Wegovy and medications like them have revolutionised weight loss in Australia and around the world in the past few years, and both are now approved for treating diabetes and your taxpayer money goes towards subsidising their cost. But the Pharmaceutical Benefits Scheme has rejected funding them for weight loss. This means that people who are overweight but do not have diabetes are looking at hundreds of dollars a month if they want to try them to lose weight. On this episode of the Briefing, we’re asking – is that the right call? Bension Siebert is joined by Jonathan Karnon, Professor in Health Economics at Flinders University’s College of Medicine and Public Health, and Lauren Ball, Professor of Community Health and Wellbeing at The University of Queensland, to help answer the question. Follow The Briefing: TikTok: @listnrnewsroom Instagram: @listnrnewsroom @thebriefingpodcast YouTube: @LiSTNRnewsroom Facebook: @LiSTNR NewsroomSee omnystudio.com/listener for privacy information.

Join Isabel and Jade for part two of their World Cancer Day special for 2025, where guest Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, Johnson & Johnson, uncovers more of his insights into the oncology space.  In this instalment, Martin shares his thoughts on improving access to innovative cancer medicines, improving public trust toward the industry and his personal leadership style.  A little more on GOLD's guest… Martin Price is Vice President for Health Economics, Market Access and Reimbursement in Europe, the Middle East and Africa, Johnson & Johnson, a role he has held for the past eight years. He leads the teams responsible for achieving optimal and accelerated market access, at a fair and value-based price, for Johnson & Johnson's new products and indications. Prior to this, Price worked in Johnson & Johnson's UK affiliate, latterly as director of external affairs, where he was responsible for market access, communications and government affairs. He joined Johnson & Johnson in 2001 from GlaxoSmithKline, where he began his career as senior health-outcomes manager. 

Join Isabel and Jade as they present a special World Cancer Day 2025 edition of the podcast. They are joined by Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, Johnson & Johnson.  In this first instalment of the conversation, Martin and Jade discuss this year's theme ‘United by Unique', the increasing importance of real-world evidence in oncology and improving access to innovative cancer medicines.   A little more on GOLD's guest… Martin Price is Vice President for Health Economics, Market Access and Reimbursement in Europe, the Middle East and Africa, Johnson & Johnson, a role he has held for the past eight years. He leads the teams responsible for achieving optimal and accelerated market access, at a fair and value-based price, for Johnson & Johnson's new products and indications. Prior to this, Price worked in Johnson & Johnson's UK affiliate, latterly as director of external affairs, where he was responsible for market access, communications and government affairs. He joined Johnson & Johnson in 2001 from GlaxoSmithKline, where he began his career as senior health-outcomes manager.

Today, we are joined by Dr. Kathy Pearson and Dr. Gregg Pearson. Dr. Kathy Pearson, strategist, systems thinking expert, and decision-making authority, is President and Founder of Enterprise Learning Solutions. She is also an Adjunct Senior Fellow at the Leonard Davis Institute of Health Economics and has served as an adjunct Associate Professor in the Operations and Information Management Department at The Wharton School, both at the University of Pennsylvania. Kathy, an award-winning educator, collaborates with Executive Education groups and global organizations across industries like healthcare, finance, and technology, including clients such as Bank of America and Coca-Cola. She holds a BS in theoretical mathematics (Auburn University), an MS in Decision Sciences (Georgia State University), and a PhD in Industrial Engineering (Northwestern University). Dr. Gregg Pearson is a Partner at ELS and an Adjunct Professor of History at Lehigh University and La Salle University. He specializes in nineteenth-century American political history, twentieth-century American cultural history, military history, the history of technology, and business leadership. Gregg spent 16 years in the packaging industry, including as Northeast Region General Manager at Ball Corporation, overseeing $350M in revenue. He holds a PhD in History from Lehigh University, an MA from La Salle University, an MS in Industrial Engineering from Northwestern University, and is a graduate of the United States Military Academy at West Point. In this episode, we delve into the historical context of Abraham Lincoln's leadership during one of America's most tumultuous times. Key topics include: • Lincoln's assembly of a diverse cabinet • Lincoln's strategic decision-making process • The importance of diversity of thought and trust in leadership We also dive into how modern leaders can cultivate humility, leverage diverse perspectives, and build trust to make informed decisions and drive their organizations forward. Dr. Kathy Pearson and Dr. Gregg Pearson's Website: https://www.elslearning.com/ - Website and live online programs: http://ims-online.com Blog: https://blog.ims-online.com/ Podcast: https://ims-online.com/podcasts/ LinkedIn: https://www.linkedin.com/in/charlesagood/ Twitter: https://twitter.com/charlesgood99 Chapters: (00:00) Introduction (01:47) Historical Context (04:09) Lincoln's Leadership Challenges (05:33) Tool: Diversity of Thought in Leadership (07:56) Lincoln's Humility (11:08) Technique: Fort Sumter Crisis Strategy (13:34) Tip: Building Trust (16:21) Emancipation Proclamation Deliberations (20:34) Tip: Decision-Making in Leadership (24:42) Lincoln's Trust and Support (27:49) Lincoln's Legacy and Leadership Lessons (31:14) Conclusion

The brazen murder of UnitedHealthcare CEO Brian Thompson in broad daylight in midtown Manhattan last year has open the floodgates to an outpouring of anger and frustration with the health insurance industry. Across the country, whether it's about skyrocketing financial costs or access to care, there seems to be a wide agreement that health insurance in America is broken. The question is how to fix it. How can policy incentivize the industry to be better stewards of the health of its members without fueling unsustainable costs or incentivizing waste? What solutions are on the table and how might they shape the future of healthcare in America? Here to help us dig into the details is Vivian Ho, the James A. Baker III Institute Chair in Health Economics at Rice University.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The U.S. healthcare system is often described as one of the most advanced in the world, yet it’s also one of the most expensive and fragmented. Millions of Americans struggle with navigating insurance networks, surprise medical bills, and soaring costs. For many, accessing basic healthcare feels more like solving a puzzle than receiving care. So… why does the U.S. spend so much more on healthcare than other countries? What role do high prices, private insurance, and systemic inefficiencies play? And most importantly, what can we do to fix it? To help us unravel these questions, we’re joined by Mustafa Hussein, an Assistant Professor of Health Economics at the CUNY Graduate School of Public Health. Mustafa specializes in health inequalities, public policy, and the socio-economic drivers of health outcomes. Today – he discusses how our system got here and what it’ll take to create meaningful reform. See omnystudio.com/listener for privacy information.

There is a natural desire on the part of governments to ensure that their future citizens -- i.e. their nation's children -- are happy, healthy and productive, and that therefore governments have policies that work to achieve that. But good intentions never guarantee good policies. Here's where economist Janet Currie steps in. Currie is the Henry Putnam Professor of Economics and Public Affairs at Princeton University, where she co-directs, with Kate Ho, the Center for Health and Wellbeing. In this Social Science Bites podcast, the pioneer in assessing the nexus of policy and parenting explains to interviewer David Edmonds how programs like Head Start in the United States and Sure Start in the United Kingdom provide real benefits over time to both their young clients as youths and later on in life. After looking at a variety of programs and interventions, she details that "the general conclusion [is] that the programs that were spending more money directly on the children tended to have better outcomes." Her findings suggest this holds true even when similar approaches don't have the same effect on adults. "[I]n the United States," she says, "if you give health insurance to adults who didn't have health insurance, they use more services, and they are happier about that, that they get to use services. But it doesn't actually seem to save very much money. On the other hand, when you cover children from a young age, that is cost effective, that does save money, and in fact, the costs of the program probably pay for themselves in terms of the reduction in illness and disability going forward." In addition to her work at Princeton, Currie is also co-director of the National Bureau of Economic Research's Program on Families and Children. She has been president of the American Economic Association for 2024 and has also served as president of the American Society of Health Economics, the Society of Labor Economics, the Eastern Economic Association, and the Western Economic Association. Two years ago, she received the Klaus J. Jacobs Research Prize "for her foundational work on the influence of context such as policy decisions, environment, or health systems on child development."

Welcome to the last podcast interview of 2024! This is the fourth season, 10th episode, which I guess puts us between 110-120 interviews so far. This week's interview with an economist, learning more about their personal story, is Ted Joyce. Ted is a Professor of Economics at Baruch College and the Graduate Center, City University of New York (CUNY), and a Research Associate with the National Bureau of Economic Research's Health Economics program. He's renowned for his contributions to demography and reproductive health policy and his work has appeared in top journals such as the Journal of Political Economy, New England Journal of Medicine, and Review of Economics and Statistics. Ted has been a role model for me ever since I graduated in 2007, graciously corresponding with me, meeting with me at conferences, and talking to me about research and navigating the ropes. He was Mike Grossman's student at CUNY, who I interviewed before and who is himself a very prominent health economist who was also one of Gary Becker's first students. As my advisor, David Mustard, was also a Becker student, that makes me and Ted cousins. So it was nice having a family reunion for this interview. Happy new year everyone. May you all be at ease, be at peace, be safe and be happy. 2025 here we come!Scott's Mixtape Substack is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Get full access to Scott's Mixtape Substack at causalinf.substack.com/subscribe

In this episode, Becker's Healthcare's Erika Spicer Mason speaks with April Spillane, Vice President of Health Economics at Barricaid. April discusses the surge in outpatient spine procedures, the challenges and opportunities surrounding reimbursement, and how innovations like Barricaid are paving the way for wider access and improved patient care in ASC settings. This episode is sponsored by Barricaid. 

In this episode, Becker's Healthcare's Erika Spicer Mason speaks with April Spillane, Vice President of Health Economics at Barricaid. April discusses the surge in outpatient spine procedures, the challenges and opportunities surrounding reimbursement, and how innovations like Barricaid are paving the way for wider access and improved patient care in ASC settings. This episode is sponsored by Barricaid. 

Are you curious about the future of health and longevity? Join Dr. Tim Jackson as he chats with Dr. David Dror, a renowned health economist, about groundbreaking innovations in the longevity space. Discover how private investments are reshaping aging, the role of technology in extending lifespans, and the global impact of health systems on wellness. Tune in for an insightful dive into the intersection of health economics, aging, and the evolving science of living longer, healthier lives.   To connect with David DROR, read the EPISODE TRANSCRIPT, links mentioned in today's episode, and more, visit: https://healyourbody.org/longevity-frontiers-redefining-aging-and-health-economics-with-david-dror-ph-d-dba/ 

Australians have a sleeping problem. The most conservative estimates show one in 10 have a sleep disorder, which is having an impact on their safety, wellbeing and productivity.This ends up costing almost a $1 billion a week. And that's not all. The total cost of inadequate sleep is thought to be as high as $75 billion a year.We're not alone either. International research shows places like the US, the UK and Europe are facing similar problems, with similar costs.Guests:Shanthakumar Rajaratnam, Chair of the Sleep Health FoundationProfessor Ron Grunstein, The Woolcock Institute Wendy Troxel, The Rand CorporationZafina Ademi, Professor of Health Economics, Monash UniversityPresenter: Richard AedyProducer: Whitney Fitzsimons This program was first broadcast on 9th May, 2024

Health Economics 101: "Code Green - How the big lie in health care affects us all." Prof. John Kellum, is a Professor of Critical Care Nephrology and now provocative author! Join us as he talks to us about his book: "Code Green - How the Big Lie in Healthcare Affects Us All." Conflict Declaration: The hosts and producers of this podcast declare no financial gain or conflict of interest from this episode or the promotion of Code Green. Our only goal is to share the insights and expertise of Dr. Kellum with our audience. Episode Chapters: Welcome and Introduction Why Code Green? The inspiration behind the book. The Evolution of U.S. Healthcare: From the 1980s to today. The "Big Lie" in Healthcare: How hospitals maintain profits while claiming financial distress. Trust and Its Erosion in Medicine: Exploring the misalignment between physicians, hospitals, and patient care. Burnout or Moral Injury? Understanding the psychological toll of compromised care. Aligning Values with Care: Dr. Kellum's actionable solutions for a better healthcare system. The Role of Patients in Reform: How patients can become advocates for systemic change. Closing Thoughts and Takeaways: Dr. Kellum's message to healthcare professionals and patients alike. Further Resources: • Code Green: How the Big Lie in Healthcare Affects Us All

This piece was recorded at the The 7th Collaborative Clinical Trials in Anaesthesiology Conference, Prato, Italy. The discussion centers around the roles and contributions of bio statisticians in clinical trials. Presented by Kate Leslie and Andy Cumpstey with their guests, Jessica Kasza, Professor of Biostatistics, Data Analytics/Modelling and Health Economics at Monash University and Elizabeth Ryan, Research Fellow at Monash University.

Welcome back to the series, Perspectives on Peace, hosted by Chris Coyne. The first four episodes of this series will focus on The Legacy of Robert Higgs (Mercatus Center, 2024) and will feature a collection of short interviews with many of the chapter authors.This episode focuses on the military and health industrial complexes of Robert Higgs, featuring authors Nathan Goodman on “The Military-­Industrial Complex and the Militarization of Society”, Raymond March on “What About the Healthcare State? Robert Higgs's Contribution to Health Economics”, and Yuliya Yatsyshina on “The War Industry as Economic Cancer.” In their conversations, the authors share the impact Robert Higgs has had on their life and career and dive into a short summary of their respective chapters.Nathan P. Goodman is a Senior Research Fellow and Senior Fellow at the F.A. Hayek Program for Advanced Study in Philosophy, Politics, and Economics at the Mercatus Center at George Mason University. Nathan is an alum of the Mercatus PhD Fellowship.Raymond J. March is an Assistant Professor of Economics at Angelo State University.Yuliya Yatsyshina is an Associate Program Director for Academic & Student Programs at the Mercatus Center at George Mason University. Yuliya is an alum of the Mercatus MA Fellowship.Learn more about Chris Coyne's work as Director of the Initiative for the Study of a Stable Peace (ISSP).If you like the show, please subscribe, leave a 5-star review, and tell others about the show! We're available on Apple Podcasts, Spotify, Amazon Music, and wherever you get your podcasts.Virtual Sentiments, our new podcast series from the Hayek Program is streaming! Subscribe today and listen to seasons one and two.Follow the Hayek Program on Twitter: @HayekProgramLearn more about Academic & Student ProgramsFollow the Mercatus Center on Twitter: @mercatusCC Music: Twisterium

Rob Abbott, CEO and Executive Director at ISPOR, the Professional Society for Health Economics and Outcomes Research, focuses on defining and measuring value in healthcare, including accessibility, affordability, effectiveness, and patient outcomes. HEOR (health economics and outcomes research) can provide data-driven insights to guide healthcare decision-making, reduce bias in research, and consider a broader range of factors like social determinants of health. This can improve treatment adherence, align therapies with what matters most to patients, and support the evaluation of technology used for treatments and predictive analysis of new therapies.   Rob explains, "I'm excited at both the legacy of work that health economics and outcomes research has contributed to, but I'm particularly excited about the extent to which health economics and outcomes research can provide data-driven insights to highlight health interventions that provide the best health outcomes for the investment made. This is good for managing the expenditure of public resources. Still, even more so, data-driven insights can help us lead to better health outcomes, better treatment protocols, and better health outcomes for patients." "As health economists and a professional society representing health economists and outcomes researchers, I think we know that historically, we have defined value quite narrowly in terms of a person's physical health, for instance. But we know that increasingly the concept of whole health or a more holistic approach to health is gaining a lot of traction. So, we are actively engaged in expanding the definition of health to include access to housing, social connections and networks, healthy food and lifestyle choices, and things of that nature. So, I think we are beginning to bring some new ideas to the table in terms of how we think about health."  #ISPOR #Patients #Healthcare #DigitalHealth #GlobalHealth #HEOR #RWE #HealthEconomics #HealthAI #DrugPriceNegotiations ISPOR.org Download the transcript here

Rob Abbott, CEO and Executive Director at ISPOR, the Professional Society for Health Economics and Outcomes Research, focuses on defining and measuring value in healthcare, including accessibility, affordability, effectiveness, and patient outcomes. HEOR (health economics and outcomes research) can provide data-driven insights to guide healthcare decision-making, reduce bias in research, and consider a broader range of factors like social determinants of health. This can improve treatment adherence, align therapies with what matters most to patients, and support the evaluation of technology used for treatments and predictive analysis of new therapies.   Rob explains, "I'm excited at both the legacy of work that health economics and outcomes research has contributed to, but I'm particularly excited about the extent to which health economics and outcomes research can provide data-driven insights to highlight health interventions that provide the best health outcomes for the investment made. This is good for managing the expenditure of public resources. Still, even more so, data-driven insights can help us lead to better health outcomes, better treatment protocols, and better health outcomes for patients." "As health economists and a professional society representing health economists and outcomes researchers, I think we know that historically, we have defined value quite narrowly in terms of a person's physical health, for instance. But we know that increasingly the concept of whole health or a more holistic approach to health is gaining a lot of traction. So, we are actively engaged in expanding the definition of health to include access to housing, social connections and networks, healthy food and lifestyle choices, and things of that nature. So, I think we are beginning to bring some new ideas to the table in terms of how we think about health."  #ISPOR #Patients #Healthcare #DigitalHealth #GlobalHealth #HEOR #RWE #HealthEconomics #HealthAI #DrugPriceNegotiations ISPOR.org Listen to the podcast here

Have you ever wondered what it takes for a startup, particularly in a niche field like women's health, to secure the necessary funding to move forward and make a meaningful impact? In this episode of The Angel Next Door Podcast, Marcia Dawood sits down with Mark Gannott, who brings a unique blend of neuroscience, economics, and entrepreneurship to the table. From navigating the complex landscape of women's health financing to shedding light on economic modeling and network strategies, Mark's insights are invaluable for anyone looking to understand the intricacies of funding in highly specialized areas.Mark Gannott, an economist and pharmacoeconomist, has a scholarly background in neuroscience and economics. His career took a pivotal turn following a personal tragedy that shifted his focus from medical school to the financing side of healthcare. With a side project in managing a massively popular social media page focused on dogs and mental health, Mark works on critical health issues, including cannabis economics and underfunded areas like endometriosis. His drive to bring more financial resources to women's health startups sets him apart as a thought leader in this space.In this enlightening conversation, Mark explores why women's health is still struggling to garner sufficient funding despite its massive economic potential. He talks about his work as a pharmacoeconomist and the significance of building financial models that make compelling cases for investment in women's health. Additionally, the episode highlights the importance of network analysis in connecting the right people to foster successful startups. Whether you're an investor, an entrepreneur, or someone passionate about women's health, this episode provides crucial insights into an often-overlooked yet vital sector. Mark's forward-thinking approach to financing and network building makes this episode a must-listen for anyone interested in transforming the landscape for women's health. To get the latest from Mark Gannott, you can follow him below!LinkedIn - https://www.linkedin.com/in/markgannott/ Sign up for Marcia's newsletter to receive tips and the latest on Angel Investing!Website: www.marciadawood.comLearn more about the documentary Show Her the Money: www.showherthemoneymovie.comAnd don't forget to follow us wherever you are!Apple Podcasts: https://pod.link/1586445642.appleSpotify: https://pod.link/1586445642.spotifyLinkedIn: https://www.linkedin.com/company/angel-next-door-podcast/Instagram: https://www.instagram.com/theangelnextdoorpodcast/TikTok: https://www.tiktok.com/@marciadawood

The South African government first proposed a 20% sugar-sweetened beverage (SSB) tax in 2016. However, after extensive consultations with the beverage and sugar industries, the levy was reduced to approximately 10%, coming into effect in April 2018. Despite this lower rate, studies up to April 2021 show that the HPL has led to significant reductions in SSB consumption, particularly among low-income groups and populations with high SSB intake. These findings suggest that the levy has been effective in improving health equity. The Healthy Living Alliance's (HEALA) released its fourth episode of the thought-provoking web series, Chew on This. The episode titled “Is the Sugar Industry Lying to Us?", critically examines the Health Promotion Levy (HPL) on sugary beverages, introduced to reduce sugar consumption and improve public health. Joining us to educate us more about this series we're joined by Prof Sue Goldstein, a public health medicine specialist, and MD of the SAMRC/Wits Centre for Health Economics and Decision Science (PRICELESS SA).See omnystudio.com/listener for privacy information.

Obesity and associated health problems cause a significant burden on health systems, but should weight-loss drugs be offered under our PBS just for weight loss?  In Britain, there is to be a trial of the weight loss drug Mounjaro, that will also seek to measure the economic impact of those benefits.  Britain's Health Minister argues that weight loss drugs will be '"life-changing, help them get back to work and ease the demands on our NHS". Guests:Dr Norman Swan, co-presenter of ABC Radio National's Health Report, and the podcast 'What's That Rash?'Jonathan Karnon, Professor of Health Economics at Flinders UniversityNial Wheate, Pharmaceutical Chemist and Professor of Academic Excellence at Macquarie University And the Albanese Government this week announced a crack down on unfair and excessive card surcharges, promising to get a better deal for Australians and small business.  The declining use of cash and the rise of electronic payments means more Australians are getting hit by often hidden surcharges.  Guest:Brad Kelly, Co-founder of the Independent Payment Forum

Many ambitious women juggle career goals, family responsibilities, and personal dreams at the cost of stress and overwhelm, but you can hustle with health and happiness.In this episode, you'll meet Dr. Christiane Schroeter, professor, podcast host, and author of the newly released book How to Master Your Goals.Christiane shares insights from her journey, highlighting the importance of self-discovery, mindset shifts, and actionable steps for achieving goals while staying true to yourself. Here's What You'll Discover in This Episode:Redefining the Hustle: Learn how to hustle without sacrificing your well-being or happiness.Balancing Ambition and Wellness: Discover how Christiane balances her leadership roles while prioritizing health and joy.The Importance of Health in Success: Understand why health impacts your ability to perform at your best in business and life.Finding Your Superpower: Explore how to uncover and leverage your unique strengths for personal and professional success.Dr. Christiane Schroeter is a passionate Business & Wellness Coach with a distinctive European flair. She focuses on helping women elevate their health and confidence, empowering them to excel in life and business.With a Ph.D. in Health Economics, she teaches Marketing, Innovation, and Entrepreneurship at a leading U.S. university, using insights from her book How to Master Your Goals. Her work has earned her numerous awards, and she connects deeply with her students.As the host of the Happy Healthy Hustle Podcast, ranked in the top 1%, and through her popular Instagram and YouTube platforms, Christiane shares practical advice on achieving wellness without being overwhelmed, inspiring her community with a motivating "Let's do it!" attitude.Hello Happy Nest, https://hellohappynest.com/Podcast: https://hellohappynest.com/podcast/Instagram: https://www.instagram.com/hello.happy.nest/YouTube: https://www.youtube.com/@hellohappynestFacebook: https://www.facebook.com/HelloHappyNestLinkedIn: https://www.linkedin.com/in/christianeschroeter/TikTok https://www.tiktok.com/@hello.happy.nestAmazon book: https://amzn.to/4dVvAsAFOLLOW MARISA ON LINKEDIN ☑️ LinkedIn: https://www.linkedin.com/in/marisashadrick/Join the Podcast Community! https://marisashadrick.com/listenTime is our most valuable asset, but it often slips away in the chaos of endless tasks.

Iowa's policymakers, providers, and insurers operate within a state comprised of an aging population and large rural areas. According to the Iowa Department of Justice, the state ranks 16th nationally for the number of residents 50-years-old and over. Approximately 18% of Iowa's more-than-three-million residents are 65 years old and older while 23% are under 18 years old. The average life expectancy in Iowa is 78.12—21st highest in the country. In addition, the United States Department of Agriculture (USDA) considers 77 of the state's 99 counties “rural” based on the amount of open countryside and rural towns. These are only some of the findings in our report titled "Iowa's Healthcare Landscape." The full report explores and presents data on Iowa's healthcare business climate, healthcare expenditures, insurance, and rural healthcare. In doing so, it highlights Iowa's unique healthcare landscape to help public- and private-sector decision makers understand the state's challenges and identify where to focus solutions to improve the state's healthcare system.   On this episode of Common Sense Digest, Host and CSI Chairman Earl Wright dives into all of these issues and more with one of the report's authors, Dr. Chelsea Lensing, CSI's Health & Wellness Fellow. Dr. Lensing shares her insights from writing this report including trends regarding the ages of doctors, access to care, obesity, diabetes and Alzheimer's rates, and much more. This episode paints a very clear picture of the state of affairs of healthcare in Iowa. To read our complete report, you can find it here. Thank you for listening to Common Sense Digest. Please rate, review, and subscribe on your favorite podcatcher. All of our podcasts can be found here. Dr. Chelsea Lensing is an assistant professor at the Stead Department of Business Administration and Economics at Coe College where she teaches Principles of Microeconomics, Health Economics, Intermediate Economics, International Economics, and Econometrics II. She previously instructed at the University of Iowa in Principles of Microeconomics and Business Statistics. Her research focuses on health, labor, and public economics with an emphasis on understanding the relationship between nutrition, obesity, and healthcare costs. Her academic work explores how health behaviors and nutrition decisions intersect, manifesting in externalities that reverberate within our healthcare system. Dr. Lensing earned a B.A. in Mathematics at Coe College and a Ph.D. in Economics at the University of Iowa.

Today, I am sharing with you my conversation with business and wellness coach, Dr. Christiane Schroeter. Christiane is a fellow podcaster and we met through a podcasting mom's group.  Her mission is to make life easier for women in business. Can we say EASE? We talk about mindset, mastering your goals, and creating your legacy - something that brings you joy.   Dr. Christiane Schroeter is a Business & Wellness Coach known for her European flair. She helps women improve their health and confidence so they can show up for their life & business differently. Christiane has a Ph.D. in Health Economics and teaches Marketing, Innovation & Entrepreneurship. She earned multiple national and international teaching and publication awards. Most of her clients find Christiane through her Happy Healthy Hustle Podcast, ranked among the TOP 1% globally. Christiane creates a community on Instagram and YouTube, sharing how to nurture your health without the overwhelm.     You don't want to miss: ●      Mastering Your Goals ●      Letting go of feeling you need to be everywhere at once ●      Most people don't notice what you notice ●      Cooking with EASE   Connect with Christiane: Hello Happy Nest, https://hellohappynest.com/ Podcast: https://hellohappynest.com/podcast/ Instagram: https://www.instagram.com/hello.happy.nest/ YouTube: https://www.youtube.com/@hellohappynest Facebook: https://www.facebook.com/HelloHappyNest LinkedIn: https://www.linkedin.com/in/christianeschroeter/ TikTok https://www.tiktok.com/@hello.happy.nest   Links and resources: ·      FREE Guided Meditation – Create an Energetic Anchor in Your Future Self Reality. Click the link to download your free 20 min guided meditation to help you visualize and manifest! ·      Private Energy Healing Session with K. Margaret – Feel stuck? These sessions can help you gain clarity, connect to your intuition and receive support and love from your spirit team. They are calm, peaceful, and transformative experiences. Go to deliciousease.com/services for more information and to book a session!  Let's connect! ●      Insta: @deliciousease ●      Pinterest: @deliciousease ●      Website: deliciousease.com ●      Join the Sparkle (Email) List: deliciousease.com/email-join   Make sure you click SUBSCRIBE so you don't miss out on any of my content coming up soon. Thank you!

Welcome to the No Labels, No Limits podcast! Today we have Dr. Schroeter, a trailblazing Ph.D. in Health Economics, who is revolutionizing wellness coaching through an innovative mix of gamification and storytelling. Dr. Schroeter's approach is designed to help women overcome low self-esteem and build confidence, transforming their health and success in both personal and professional realms.In this episode, we'll dive into:Innovative Wellness Tips: Discover actionable strategies for making healthy snacks more accessible and incorporating petite practices into your busy life. Learn how small, manageable changes can lead to significant improvements in your overall well-being.Gamification Fun: Explore how gamification can make adopting new wellness habits a fun and rewarding experience. From setting playful challenges to tracking progress with a game-like approach, find out how to make self-care engaging and enjoyable.Visual Strategies: Get creative with visual techniques that make your wellness journey more engaging. Learn how to use visual cues, reminders, and fun visuals to keep you motivated and excited about your health goals.Join us and discover a refreshing approach to wellness that fits seamlessly into your busy life. With Dr. Schroeter's innovative strategies and playful techniques, you'll find new ways to nurture your health and confidence while having fun along the way. Tune in to unlock practical tips, inspiring stories, and engaging games that make self-care both achievable and enjoyable. Embrace a happier, healthier you and turn every day into a new opportunity for growth and success.Dr. Schroeter reminds us that "Stepping out of your comfort zone can lead to the most unexpected and rewarding adventures. Ooh la la!"Don't miss out—subscribe now and start your journey towards a more vibrant life today!Gift: Petite Practice Planner Hello Happy Nest | Business & Wellness CoachConnect and Learn more with Christiane Schroeter: Website: Hello Happy Nest | Business & Wellness CoachInstagram: https://www.instagram.com/hello.happy.nest/Podcast: https://hellohappynest.com/podcast/YouTube: https://www.youtube.com/@hellohappynestFacebook: https://www.facebook.com/HelloHappyNestTikTok: https://www.tiktok.com/@hello.happy.nestLinkedIn: https://www.linkedin.com/in/christianeschroeter/Connect and Learn more with Sarah Boxx: The SandBoxx offers Nonprofit business consulting and coaching for leaders. (sarahboxx.com)#WellnessJourney #HealthyLiving #HealthAndWellness #HealthyHabits #NLNL Get bonus content on Patreon Hosted on Acast. See acast.com/privacy for more information.

Bill Padula, PhD, Assistant Professor of Pharmaceutical and Health Economics, and Dr. David Armstrong, professor of surgery and Neurological surgery, are both at the University of Southern California and are concerned about wound care and the impact of potential changes in Medicare reimbursement of skin substitutes. They discuss the importance of skin substitutes in chronic wound care and their effectiveness in reducing amputations and hospital readmissions. With current advancements in wound care,  there is an emphasis on the need for education and advocacy to ensure that Medicare understands the value of skin substitutes and their potential for improving patient outcomes. David explains, "The skin substitutes we are talking about have been really helpful over the past, maybe at least the last decade, maybe even the last two decades, and especially over the last few years. We've seen now in some studies from our group and others that we can not only reduce amputation, but we can also reduce hospital admission and emergency department admission for these patients. So it's a really exciting time. And so that's on the positive end. On the not so positive end is that there have been some changes, and I'm sure Dr. Padula can talk about this. That may limit our access to it as clinicians, which is concerning certainly for the patients that I'm having right across the hallway." Bill elaborates, "Up until recently, Medicare hasn't put a lot of governance on reimbursement for skin substitutes, and physicians have been using them autonomously with the patient to treat non-healing chronic wounds. We see from the data that these skin substitutes work best when applied on a patient every one to seven days in a wound clinic, like what David Armstrong runs here at the University of Southern California. Medicare wants to change the reimbursement pattern and reduce reimbursement so that it would be impossible to get reimbursed for more than ten applications of a skin substitute in twelve weeks. So, that reimbursement system makes it impossible for providers and patients to follow parameters for use and improve the likelihood of healing a chronic wound." #SkinSubstitute #Medicare #CMS #ChronicWounds  Keck School of Medicine at USC Download the transcript here

In this episode of the MindHealth360 Show, we explore the future of healthcare with James Maskell, a pioneering advocate for functional and integrative medicine, author of “The Evolution of Medicine” and “The Community Cure” (check titles), and founder of the largest global network of functional medicine educational and practitioner groups, the  “Functional Forum”. Mr. Maskell discusses the growing burden of chronic diseases, the limitations of conventional medicine and how functional medicine addresses the root causes of illness, as well as the importance of community based care for healing. Mr. Maskell has been at the forefront of efforts to make functional medicine more accessible and effective at scale. The conversation covers the development of community-based healthcare models, such as group medical visits, which combine the power of social connection with medical care. Mr. Maskell explains how these models can enhance patient outcomes, reduce healthcare costs, and address psychosocial factors that contribute to chronic disease. He emphasises the need for a shift toward participatory and preventive healthcare, where patients are active participants in their health journey. In this episode, you'll learn about: - The Role of Functional Medicine in Chronic Disease Management: explore how functional medicine's root cause approach can reverse chronic diseases by focusing on personalised care, and lifestyle interventions while simultaneously addressing underlying physiological imbalances. - Innovative Group Medical Visits: learn about the implementation and effectiveness of group medical visits in functional medicine. These visits not only address the medical needs of patients but also provide social support, which is crucial for improving outcomes in chronic illness and mental health. - Health Economics and Functional Medicine: understand the financial implications of adopting functional medicine in healthcare systems. Mr. Maskell discusses how functional medicine can lead to significant cost savings by reducing the need for chronic disease management through medications and frequent hospitalisations. - Psychosocial and Psychospiritual Factors in Healthcare: mr. Maskell highlights the importance of addressing psychosocial determinants of health, such as loneliness and stress, which are often overlooked in traditional medicine but are critical for effective chronic disease management. - Integration of Functional Medicine into Mainstream Healthcare: discover the challenges and opportunities in bringing functional medicine into mainstream healthcare systems, including overcoming resistance from traditional medical practices and the pharmaceutical industry. - The Impact of Community in Healthcare: mr. Maskell's work demonstrates how community-based approaches can enhance patient engagement, adherence to treatment plans, and overall well-being, particularly in managing complex, chronic conditions. - The Future of Functional Medicine: insights into how technology and data-driven approaches are being integrated into functional medicine to improve diagnostic accuracy, treatment personalisation and scalability of care models. Guest's Social Media Channels: - Website: https://www.jamesmaskell.com/ - Instagram: @mrjamesmaskell -LinkedIn: https://www.linkedin.com/in/jamesmaskell/ Publications: - Maskell, J. (2014). The Evolution of Medicine: Join the Movement to Solve Chronic Disease and Fall Back in Love with Medicine - Maskell, J. (2019). The Community Cure: Transforming Health Outcomes Together  

In this episode, we're joined by Dr. Oluwadamilola "Lola" Fayanju, a leader in breast cancer care and health equity. With a remarkable background that spans clinical excellence and innovative research, Dr. Fayanju holds the Helen O. Dickens Presidential Associate Professorship at the University of Pennsylvania (PENN) and serves as Chief of Breast Surgery at Penn Medicine. She also leads as the Surgical Director of the Rena Rowan Breast Center, directs Health Equity Innovation at the Penn Center for Cancer Care Innovation, and is a Senior Fellow at the Leonard Davis Institute of Health Economics.

My conversation today is with Will Shrank, MD. Dr. Shrank led the evaluation group at CMMI (Center for Medicare and Medicaid Innovation). He has spent time in the private sector, first at CVS Health and UPMC (University of Pittsburgh Medical Center) as chief medical officer of the health plan in Pittsburgh, and then as the chief medical officer for Humana. Now he is a venture partner at Andreessen Horowitz and doing some consulting for CMMI. To read the full article and show notes which include mentioned links, visit the episode page.  If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. We start out this conversation talking about waste in healthcare. In fact, Dr. Shrank was on a team who did a study about waste in the US healthcare system. (The article is, unfortunately, paywalled.) In that study, it says estimates suggest we have upwards of a trillion dollars of waste a year. This waste can be categorized into administrative and clinical failures. Dr. Shrank emphasizes the need for aligning incentives with higher quality care, paying for patient outcomes, and highlights the potential rising power of PCPs. The discussion covers the progress made towards value-based care, the challenges faced by the current fee-for-service model, and the future landscape of primary care and healthcare delivery. In sum, we have a waste problem in this country. Aligning incentives might be one way to curb that waste. 06:54 Can we cut healthcare waste while improving patient care? 07:33 What does “healthcare waste” consist of? 07:46 What are the six categories of “healthcare waste”? 10:23 EP363 with David Scheinker, PhD. 10:37 How much money does Dr. Shrank estimate is wasted each year in healthcare? 13:09 Where is that healthcare waste going, and why does it happen? 20:07 Uncaring by Robert Pearl, MD. 21:18 “We've built a backbone of extraordinary waste on a fee-for-service chassis.” 22:16 EP409 with Larry Bauer, MSW, MEd. 24:24 EP359 with Dan O'Neill. 26:02 Dr. Shrank's warning to providers out there. 30:03 Summer Shorts 2 with Scott Conard, MD. 31:41 Why there might be a generational shift among younger providers looking to work with different models.

Since the start of the pandemic (and really, before that), frontline healthcare workers have been rightfully lauded for the tireless work that they have done to keep the healthcare system from cratering in this country. This is no easy task, as we have seen the devastation that the pandemic has wrought among our communities, and especially within the healthcare field. In Southern California, the cost of living crisis has filtered into the workplace, with many healthcare workers finding themselves priced out of their neighborhoods due to rising costs and unchecked gentrification, their stagnant wages and dwindling access to healthcare benefits compounding an already untenable situation. More than 2,200 healthcare workers at Keck Medicine at the University of Southern California are fighting for improved working conditions and a chance to combat the cost of living crisis with a new contract. So far, they have been met with an aggressive management that is hellbent on freezing wages and striking some of the most important benefits that healthcare workers enjoy from the contract. Represented by the National Union of Healthcare Workers, or NUHW, these workers - medical technicians, respiratory therapists, licensed vocational nurses, housekeepers and nursing assistants - have made clear their demands for improved working conditions at multiple USC healthcare facilities across Los Angeles, and we've brought on Francisco Cendejas and Noemi Aguirre, two worker-organizers at Keck Medicine, to talk about the ongoing contract negotiations.Note: This episode was recorded on July 18th, 2024. Negotiations with Keck-USC are still ongoing.Additional links/info below…NUHW - Keck-USC Negotiations FactsheetPenn Leonard Davis Institute of Health Economics, “How Inadequate Hospital Staffing Continues to Burn Out Nurses and Threaten Patients”National Union of Healthcare Workers - Main SitePermanent links below...Leave us a voicemail and we might play it on the show!Labor Radio / Podcast Network website, Facebook page, and Twitter pageIn These Times website, Facebook page, and Twitter pageThe Real News Network website, YouTube channel, podcast feeds, Facebook page, and Twitter pageFeatured Music...Jules Taylor, "Working People" Theme SongHelp us continue producing radically independent news and in-depth analysis by following us and becoming a monthly sustainer.Sign up for our newsletterLike us on FacebookFollow us on TwitterDonate to support this podcast

Minimum wage workers, especially those with children, face barriers to affordable child care. Child care costs can prevent working parents who earn minimum wage from participating in the labor market. Alternately, many child-care workers also face financial barriers because they, too, earn minimal wages. Therefore, increasing the minimum wage would alleviate financial burdens for both parents and child-care workers. In this episode, both Dr. Anna Godøy and Dr. Jennie Romich discuss their research on minimum wage and its effects on parental labor supply and the child care sector. Anna Godøy is a Senior Research Fellow at the Ragnar Frisch Center for Economic Research and an Associate Professor at the Department of Health Management and Health Economics at the University of Oslo, Norway. Her research interests include empirical labor economics, health economics, and policy evaluation. Dr. Jennie Romich is an Associate Professor of Social Work at the University of Washington, director of the West Coast Poverty Center, an active member of the Center for Studies of Demography and Ecology, and an IRP affiliate. Romich studies resources and economic well-being in families with a particular emphasis on low-income workers, household budgets, and families' interactions with public policy. Reference Papers: Parental Labor Supply: Evidence from Minimum Wage Changes  Responding to an increased minimum wage: A mixed methods study of child care businesses during the implementation of Seattle's minimum wage ordinance How will higher minimum wages affect family life and children's well‐being?    

In a recent address, U.S. Secretary of the Treasury Janet Yellen said, “It is still too hard to be a working parent.” Her words highlight a significant challenge in America, especially for mothers. Inspired by my college research paper, we'll dive into the American childcare system and its negative impact on working women. We will start with an overview of the current state of the U.S. childcare system. and then discuss how traditional gender norms exacerbate the issue. Following this, we'll examine the direct effects of childcare challenges on women's career paths, and consider some interesting potential solutions to the childcare crisis. I'm no expert, but I have researched this topic extensively and hope to provide an informative and engaging discussion!Support the Show.

I'm super excited about today's episode with Dr. Jordan Frey. He's a plastic surgeon and the Prudent Plastic Surgeon blog and website founder. I stumbled upon his work during a deep dive into the financial viability of becoming a doctor. With the high costs of medical training and increasing burnout rates among doctors and medical professionals, I wanted to dig into the financial aspects of pursuing a career in medicine. Is it still worth it, financially, to become a doctor? While it's undeniably a gratifying and fantastic career, I'm curious about the financial side of things. I hope you enjoy the interview!The Prudent Plastic SurgeonSupport the Show.

How well do you fail? Bethrah Szumski, former APP president, former APP secretary, studio owner, and all around boss comes back to the show. I wanted to make episode 250 (thank you, by the way) special, and that meant having a guest with something to say. Admittedly we didn't have much of a plan going in to this one. Bethrah was kind in offering to record a conversation shortly after she arrived to Las Vegas for the 2024 APP conference. Bethrah has always been someone who will just tell it like it is. Content warning, we will talk about mental health and therapy, we'll talk about the current economy and how it is strangling many shops, and we'll talk about a few other things that loosely fit into the "career goals" column. I have other various stuff to promote, but just go to www.ryanpba.com for that. New videos, new merch, new class announcements, yadda yadda.

Dr. Jay Bhattacharya is a professor of medicine, economics, and health research policy at Stanford University, where he is also the director of Stanford's Center for Demography and Economics of Health and Aging. After dedicating much of his career to studying the economics of health care, when the COVID-19 crisis began, Dr. Bhattacharya shifted his research focus to the epidemiology of COVID-19, the lethality of COVID-19 infection, and the effectiveness and effects of lockdown policies. This led him to co-author an open letter, The Great Barrington Declaration, which advocated for a lift of restrictions on lower-risk groups to develop herd immunity. He is also the co-author of the widely acclaimed textbook Health Economics, a staple in undergraduate and graduate curricula worldwide. He holds four degrees from Stanford: a BA, an AM, an MD, and a PhD in economics. ------ Thank you to the sponsors that fuel our podcast and our team: Lucy https://lucy.co/tetra ------ LMNT Electrolytes https://drinklmnt.com/tetra ------ Squarespace https://squarespace.com/tetra ------ House of Macadamias https://www.houseofmacadamias.com/tetra